CHM.AX Chimeric Therapeutics Limited
Company Analysis
Latest News
🔴 Chimeric Therapeutics is trading 5.26% down today after CHM-2101 Phase 1 dosing ceased
Chimeric Therapeutics is trading 5.26% down now at A$0.02 after resuming trading following the August 19 disclosure that enrolment and dosing in the CHM-2101...
🟢 Chimeric Therapeutics is trading 5% up today after CHM-2101 trial halted
Chimeric Therapeutics is trading 5.26% up now at A$0.02 after resuming trading on August 19, 2026, following disclosure that enrolment and dosing ceased; the...
Chimeric Halts Its Lead Cancer Trial and Loses Nearly Half Its Value — Can a Micro-Cap Biotech Survive Without Its Main Bet?
Shares of Chimeric Therapeutics cratered 45.7% to A$0.02 on August 19, 2026, after the Australian cell therapy company resumed trading and revealed it had...
🔴 Chimeric Therapeutics (CHM.AX) Plunges 45.71% Amidst Creditor Negotiation Plans
Chimeric Therapeutics is trading 45.71% down today at A$0.02** after announcing its intention to enter negotiations with its creditors. * Trading resumed...
🔴 Chimeric Therapeutics is trading 54.29% down today after resuming from a trading halt
Chimeric Therapeutics is trading 54.29% down at A$0.02 after resuming from a trading halt on August 19, 2026; available evidence does not identify a confirmed...
Chimeric Therapeutics Halts Trading on ASX Pending CDH17 Clinical Trial Results
Chimeric Therapeutics (ASX:CHM) has entered a trading halt on the Australian Securities Exchange as of August 17, 2026. The halt was requested by the company...
🔴 Chimeric Therapeutics is trading 12.5% down today with no confirmed company-specific catalyst
Chimeric Therapeutics is trading at A$0.04, down 12.50%, with no confirmed company-specific catalyst identified for August 17, 2026. • Recent announcements...
🔴 Chimeric Therapeutics is trading 10% down today
Chimeric Therapeutics is trading 10% down now at A$0.04 after no confirmed company-specific catalyst was identified for August 14, 2026. - Recent financing...
🔴 Chimeric Therapeutics is trading 5% down with no confirmed catalyst identified
Chimeric Therapeutics is trading 5% down at A$0.04, with no confirmed company-specific catalyst identified. - No clear company-specific announcement dated...
🟢 Chimeric Therapeutics is trading 5% up today amid stronger biotech sentiment
Chimeric Therapeutics is trading 5.13% up at A$0.04 after the August 7, 2026 session, amid stronger biotech sentiment. - No clear company-specific...
🟢 Chimeric Therapeutics is trading 5% up today amid stronger biotech sentiment
Chimeric Therapeutics is trading at A$0.04, up +5.13%, amid stronger biotech sentiment. - No new company-specific announcement, clinical update, earnings...
🔴 Chimeric Therapeutics is trading 9.30% down today amid unexplained volatility
Chimeric Therapeutics is trading 9.30% down now at A$0.04, with the decline classified as unexplained volatility after a volatile August 6, 2026 session. - No...
🔴 Chimeric Therapeutics is trading 7% down today amid typical volatility
Chimeric Therapeutics is trading 6.98% down at A$0.04 today, a move driven by usual trading volatility rather than any new fundamental developments. • No...
🟢 Chimeric Therapeutics is trading 5% up today
Chimeric Therapeutics is trading at A$0.04 (+5%) today, with the move appearing to be driven by broader sector sentiment rather than a company-specific...
Chimeric Therapeutics launches strategic review, balancing 60% trial success against cash crunch
Chimeric Therapeutics has initiated a strategic review to maximize shareholder value. The company reported A$0.8 million in cash at the end of the June 2026...
🟢 Chimeric Therapeutics surges on securing R&D Tax Incentive Funding
• Chimeric Therapeutics has seen its stock jump, likely driven by the recent announcement that it secured A$1.62 million in funding. • This funding, an advance...
Chimeric Therapeutics Rebounds 19% on No News — But Can Bargain Hunters Turn a Penny Stock Around?
Shares of Chimeric Therapeutics (CHM.AX) jumped 19.4% to A$0.04 on Tuesday as opportunistic buyers scooped up stock following a pullback from roughly A$0.05 in...
🟢 Chimeric Therapeutics surges 13.16% today driven by positive Phase 1/2 clinical trial data and recent capital restructure
Chimeric Therapeutics is trading approximately 13.16% up today at A$0.04. • The significant upward movement follows positive interim results from its Phase 1/2...
🟢 Chimeric Therapeutics is trading 5.6% up today on bargain hunting after recent weakness
Chimeric Therapeutics is trading 5.6% up at A$0.04 as buyers step in following recent share price weakness. • The move is described as bargain hunting...
🟢 Chimeric Therapeutics is trading 5.6% up today on bargain hunting after recent weakness
Chimeric Therapeutics is trading 5.6% up at A$0.04 as the stock rebounds from recent selling pressure. • The move is being attributed to bargain hunting after...